April 2023 FDA Recall Drug by Pharmacy Plus, Inc. Dba Vital Care Compounder
D-0538-2023 - Lack of assurance of sterility.

This Class II drug recall was voluntarily initiated by Pharmacy Plus, Inc. Dba Vital Care Compounder on April 13, 2023 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility.. The product was distributed in MS only and the recall is currently ongoing.

Recall Number: D-0538-2023

Reason for Recall
Lack of assurance of sterility.
Initiated
04-13-2023
Reported
04-26-2023
Quantity
45 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92121
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Pharmacy Plus, Inc. dba Vital Care Compounder
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
MS only
Product Description About Product Description
Full technical description of the product.
C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402

Batch or Lot Expiration Information

Lot# : 73810, Exp. Date 5/1/2023